Which Is The Better Choice? Perseon Corp (PRSN) and NovaBay Pharmaceuticals Inc (NBY)

Posted by admin April 6, 2015 0 Comment 799 views

New York, NY – GDP INSIDER  –  04/06/2015.

This article discusses two companies: Perseon Corp (NASDAQ:PRSN) and NovaBay Pharmaceuticals Inc (NYSEMKT:NBY)

Perseon Corp (NASDAQ:PRSN) dropped sharply on Thursday with the stock losing 26.83% or $0.11 to close at $0.30, on very heavy trading of 1.370 million shares, compared to its three month average trading volume of 0.4 million. The developer and manufacturer of medical service systems to use microwave energy to treat diseases started to fall after it announced that it has completed the sale of its hyperthermia assets to Pyrexar Medical. The stock has been declining for most of the last 52 weeks and is now down 15.49% YTD, significantly underperforming the S&P 500 which has gain 0.39% over the same period. With quarterly revenue growth falling 36.60% year on year and diluted EPS of -$0.21 the fundamentals are not especially strong, but with a current ratio of 6.18, it has plenty of liquidity at the moment. Overall, the stock is not looking like it will make significant gains at this time, making it a sell rather than a hold.

Can Perseon Corp Reverse Its Current Trend? Read Our Free PRSN Analysis To Find Out.

NovaBay Pharmaceuticals Inc (NYSEMKT:NBY) continued its strong upward trend on Thursday with the stock gaining another 18.46% or $0.1348 to close at $0.8650 with more than 1.428 million shares changing hands, compared to its three month average trading volume of 0.261 million. The clinical stage biotechnology company focused on developing anti-infective compounds to treat infection has been gaining every since it released very positive fourth quarter and full year results at the end of March. The company is pursuing an aggressive sales strategy and has more than doubled its sales force promoting its flagship product Avenova. The stock had been underperforming the S&P 500 for most of this year so far, but its recent gains have propelled the stock price to a gain of 37.29% YTD. With RSI now at 75.86 and positively diverging MACD the stock looks like it is heading for a new trading level, making it a strong hold for now.

 Will NovaBay Pharmaceuticals Inc Maintain Its Current Gains? Click Here For Free NBY Analysis.

About UltimateStockAlerts

UltimateStockAlerts.com provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word ULTIMATE to 555888 from your cell phone.

UltimateStockAlerts continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.

Disclosure:  UltimateStockAlerts is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit www.UltimateStockAlerts.com website, for complete risks and disclosures.

Write Your Comment